Stevens‐Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study

作者: Osward Y. Carrasquillo , Marely Santiago‐Vazquez , Rocio Cardona , Mariana Cruz‐Manzano , Luz D. Figueroa

DOI: 10.1111/IJD.14493

关键词: ComplicationSeverity of illnessToxic epidermal necrolysisRetrospective cohort studyEtiologyTrimethoprimInternal medicineCohort studyMedicineMortality rate

摘要: BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare potentially life-threatening mucocutaneous reactions. Given their rarity, limited cohort studies have been done. The aim of this study is to evaluate compare the demographics, etiology, management, clinical laboratory characteristics, complications, outcome SJS/TEN patients seen by inpatient dermatology service at University Puerto Rico. METHODS A retrospective review 30 cases with identified diagnosis SJS, overlap SJS/TEN, or TEN who were consulted Dermatology Department Rico from 2006 2017. RESULTS total 24 adult six pediatric reviewed. Females predominant a female male ratio 1.3 : 1. most frequent offending drugs antibiotics (56.7%), anticonvulsants (23.3%), nonsteroidal anti-inflammatory (NSAIDs) (16.7%) antibiotic being trimethoprim/sulfamethoxazole (23.3%). Seventy percent experienced least one complication, often infectious etiology (80.1%). During hospital course, 73% received pharmacologic therapy (23% IVIG alone, 17% steroids 33% both) versus 27% which only supportive care. Mortality rate in was 13.8%. When comparing SCORTEN day admission, deceased had mean 1 4.0, while survivors an average 1.54 (P < 0.001). CONCLUSION Antibiotics followed frequently within study.

参考文章(43)
J. M. Mulvey, A. Padowitz, M. Lindley-Jones, R. Nickels, Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesthesia and Intensive Care. ,vol. 35, pp. 414- 417 ,(2007) , 10.1177/0310057X0703500317
Nicole Mittmann, Sandra R. Knowles, Marika Koo, Neil H. Shear, Anita Rachlis, Sean B. Rourke, Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort An Observational, Retrospective Case Series Study American Journal of Clinical Dermatology. ,vol. 13, pp. 49- 54 ,(2012) , 10.2165/11593240-000000000-00000
Ousmane Faye, Jean-Claude Roujeau, Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg) Drugs. ,vol. 65, pp. 2085- 2090 ,(2005) , 10.2165/00003495-200565150-00002
Jürgen Schneck, Jean-Paul Fagot, Peggy Sekula, Bruno Sassolas, Jean Claude Roujeau, Maja Mockenhaupt, Effects of Treatments on the Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Study on Patients Included in the Prospective EuroSCAR Study Journal of The American Academy of Dermatology. ,vol. 58, pp. 33- 40 ,(2008) , 10.1016/J.JAAD.2007.08.039
CHARLES M. GINSBURG, Stevens-Johnson Syndrome in Children Pediatric Infectious Disease. ,vol. 1, pp. 155- 158 ,(1982) , 10.1097/00006454-198205000-00005
Maja Mockenhaupt, The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis Expert Review of Clinical Immunology. ,vol. 7, pp. 803- 815 ,(2011) , 10.1586/ECI.11.66
Nathalie Fouchard, M. Bertocchi, Jean-Claude Roujeau, Jean Revuz, Pierre Wolkenstein, Sylvie Bastuji-Garin, SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis Journal of Investigative Dermatology. ,vol. 115, pp. 149- 153 ,(2000) , 10.1046/J.1523-1747.2000.00061.X
Meng Fu, Yang Gao, Yuefei Pan, Wei Li, Wenjun Liao, Gang Wang, Chunying Li, Chengxin Li, Tianwen Gao, Yufeng Liu, None, Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response. PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0045516
Jennifer T. Trent, Robert S. Kirsner, Paolo Romanelli, Francisco A. Kerdel, Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Archives of Dermatology. ,vol. 139, pp. 39- 43 ,(2003) , 10.1001/ARCHDERM.139.1.39